Published in Nucl Med Commun on April 01, 1990
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer (2002) 2.80
Optimizing nebulization practice within a large teaching hospital: easier said than done. Respir Med (1995) 2.74
Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res (1989) 2.71
Radionuclide migration through the genital tract in infertile women with endometriosis. Hum Reprod (1993) 2.67
Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am (1996) 2.37
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
The deterioration of hearing with age: frequency selectivity, the critical ratio, the audiogram, and speech threshold. J Acoust Soc Am (1982) 2.29
Membrane redistribution of the Escherichia coli MinD protein induced by MinE. J Bacteriol (2000) 2.25
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax (2001) 2.24
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg (2004) 2.14
Lung cancer: the importance of seeing a respiratory physician. Eur Respir J (2003) 2.08
Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol (2005) 2.04
Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer (2001) 1.97
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol (1998) 1.92
Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer (1998) 1.88
Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy (1985) 1.64
Treatment of pulmonary aspergilloma with itraconazole. Thorax (1991) 1.63
Emergency surgery for stab wounds to the heart. Ann R Coll Surg Engl (1983) 1.57
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer (1996) 1.57
Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology (2005) 1.55
Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol (Oxf) (1992) 1.48
The Kushida Index as a screening tool for obstructive sleep apnoea-hypopnoea syndrome. Br Dent J (2012) 1.40
Long-term continuous positive airway pressure (CPAP) outcomes from a sleep service using limited sleep studies and daycase CPAP titration in the management of obstructive sleep apnoea/hypopnoea syndrome. Chron Respir Dis (2004) 1.40
Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer. Endocr Pract (2001) 1.39
The attitudes of general dental practitioners and medical specialists to the provision of intra-oral appliances for the management of snoring and sleep apnoea. Br Dent J (2008) 1.37
Tc-99m MDP uptake in hepatoblastoma. Clin Nucl Med (1989) 1.37
Staging of non-small cell lung cancer (NSCLC): a review. Respir Med (2010) 1.33
Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun Adhes (2001) 1.31
Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol (1991) 1.30
Traumatic rupture of the ascending aorta and aortic valve following blunt chest trauma. J Thorac Cardiovasc Surg (1977) 1.23
A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol (1984) 1.21
Fatal retroperitoneal haemorrhage complicating anticoagulant therapy. Postgrad Med J (1979) 1.21
Antioxidants: their role in pregnancy and miscarriage. Antioxid Redox Signal (2000) 1.16
Myocardial infarction caused by coronary artery damage from blunt chest injury. Br Heart J (1987) 1.11
Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol (1996) 1.11
Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. J Nucl Med (1985) 1.11
Lung cancer--management and outcome in Glasgow, 1991-92. Br J Cancer (1998) 1.11
Pulmonary thromboembolism presenting as abdominal pain. Br Med J (Clin Res Ed) (1984) 1.10
The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol (2006) 1.10
The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. Biochem Pharmacol (1990) 1.10
Information for patients and staff concerning nuclear medicine. Nucl Med Commun (1992) 1.08
The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer (1981) 1.08
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J (1983) 1.07
Are dependency and self-criticism risk factors for major depressive disorder? Can J Psychiatry (1997) 1.07
Penetrating cardiac injuries in the United Kingdom. Thorax (1983) 1.07
Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg (1990) 1.07
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer (1991) 1.07
A structured approach to the interpretation and reporting of ventilation/perfusion scans. Nucl Med Commun (1998) 1.06
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. Br J Cancer (1988) 1.05
Transfer of medical technology from a developed to a developing country. J Biomed Eng (1988) 1.05
Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement? Br Med J (Clin Res Ed) (1986) 1.05
Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension. Br J Clin Pharmacol (1976) 1.04
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. Eur J Cancer Clin Oncol (1984) 1.02
Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun (1987) 1.02
The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol (Oxf) (1991) 1.02
The acute abdomen following cardiopulmonary bypass surgery. Br J Surg (1980) 1.02
Evaluation of thallium-201 exercise scintigraphy in coronary heart disease. Br Heart J (1979) 1.01
Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health (1998) 1.01
Anomalous origin of the left coronary artery from the pulmonary artery with coronary artery steal in adults. Report of two cases and review of the literature. Thorax (1976) 1.00
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. Br J Cancer (1991) 0.99
Bone scintigraphy in benign bone disease. Br Med J (Clin Res Ed) (1984) 0.99
Antibody measurement in extrinsic allergic alveolitis. Eur J Respir Dis (1984) 0.98
Re-expansion pulmonary oedema: a potentially serious complication of delayed diagnosis of pneumothorax. Br Med J (Clin Res Ed) (1985) 0.97
The role of bone scanning in osteomalacia. J Nucl Med (1978) 0.97
Understanding patients: let's talk about it. A study of cancer communication. Support Care Cancer (1996) 0.96
Changes in cerebral perfusion after acute head injury: comparison of CT with Tc-99m HM-PAO SPECT. Radiology (1987) 0.96
Longitudinal course of extrinsic allergic alveolitis in pigeon breeders. Thorax (1989) 0.95
Decreased oesophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol (1988) 0.95
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer. J Clin Oncol (1995) 0.94
Clearance of 99mTc-DTPA in pigeon fancier's hypersensitivity pneumonitis. Am Rev Respir Dis (1990) 0.94
Longitudinal study of resting energy expenditure, body cell mass and the inflammatory response in male patients with non-small cell lung cancer. Lung Cancer (2001) 0.94
Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol (1981) 0.94
Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines. Int J Radiat Oncol Biol Phys (1994) 0.93
Serological cross-reactivity among chlamydial strains in a family outbreak of psittacosis. J Infect (1989) 0.93
Relationships between avian exposure, humoral immune response, and pigeon breeders' disease among Scottish pigeon fanciers. Thorax (1986) 0.93
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung. Cancer Chemother Pharmacol (1985) 0.92
The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. Br J Cancer (1990) 0.92
Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med (1998) 0.92
Mechanism of 201Tl uptake in tumours. Eur J Nucl Med (1989) 0.91
Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol (1989) 0.91
Tumor and infection localization in AIDS patients: Ga-67 and Tl-201 findings. Clin Nucl Med (1998) 0.91
Abnormal haemostasis in small cell lung cancer. Thorax (1988) 0.91
Pulmonary infiltrates--diagnostic problems in lymphoma. Postgrad Med J (1989) 0.91
Ophthalmopathy in early thyrotoxicosis--relationship to thyroid receptor antibodies and effects of treatment. Scott Med J (1990) 0.91
Intrathoracic neural tumours. Thorax (1978) 0.90
The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease. Acta Endocrinol (Copenh) (1989) 0.90
Brucellosis: appearance on skeletal imaging. Clin Nucl Med (1988) 0.90
Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med (1989) 0.90
Actinomycosis presenting as carcinoma. Postgrad Med J (1995) 0.90
Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment? Postgrad Med J (1987) 0.90
Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients. Thorax (1982) 0.90
Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration. Cancer (1988) 0.89